Status:
COMPLETED
Efficacy and Safety of Etomidate Sedation in Gastric Endoscopic Submucosal Dissection
Lead Sponsor:
Korea University Anam Hospital
Conditions:
Sedation Complication
Endoscopic Submucosal Dissection
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
During endoscopy, the patient is sedated to relieve pain and improve the ease of the procedure. Sedation endoscopy using propofol is effective, but has the disadvantage that cardiopulmonary side effec...
Eligibility Criteria
Inclusion
- Age 19-80
- American Society of Anesthesiologists Physical Status Classification System (ASA) score of I, II, III
- Scheduled endoscopy
Exclusion
- Pregnancy
- Previous study History of hypersensitivity to drugs or substances containing soy or egg ingredients
- Those who think that tracheal intubation will be difficult
- Obstructive sleep apnea
- History of side effects from previous sedatives
- People with severe liver disease, kidney disease, or heart disease
- Those who want a non-sleeping endoscope
- A person who refuses to provide consent
- SBP \< 80mmHg or SpO2 \< 90%
- Patients with adrenocortical dysfunction, chronic steroid users
Key Trial Info
Start Date :
June 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 24 2022
Estimated Enrollment :
138 Patients enrolled
Trial Details
Trial ID
NCT05407870
Start Date
June 9 2022
End Date
November 24 2022
Last Update
November 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, Seoung-buk Gu, South Korea, 02841